0001785530-19-000001.txt : 20190815 0001785530-19-000001.hdr.sgml : 20190815 20190815131831 ACCESSION NUMBER: 0001785530-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190815 DATE AS OF CHANGE: 20190815 EFFECTIVENESS DATE: 20190815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Werewolf Therapeutics, Inc. CENTRAL INDEX KEY: 0001785530 IRS NUMBER: 823523180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-346661 FILM NUMBER: 191029529 BUSINESS ADDRESS: STREET 1: 1030 MASSACHUSETTS AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 617-952-0555 MAIL ADDRESS: STREET 1: 1030 MASSACHUSETTS AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 D 1 primary_doc.xml X0708 D LIVE 0001785530 Werewolf Therapeutics, Inc. 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA MASSACHUSETTS 02138 617-952-0555 DELAWARE None None Corporation true 2017 Daniel Hicklin 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Executive Officer Director David Cordo 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Executive Officer Luke Evnin 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Patrick Baeuerle 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Christoph Westphal 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Sakae Asanuma 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Alon Lazarus 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Pharmaceuticals Decline to Disclose 06b false 2019-08-02 true true false 0 57672595 31572600 26099995 false 9 0 0 0 false Werewolf Therapeutics, Inc. /s/ Daniel Hicklin Daniel Hicklin President and Chief Executive Officer 2019-08-15